These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 8964033)

  • 1. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.
    Bergogne-Bérézin E; Towner KJ
    Clin Microbiol Rev; 1996 Apr; 9(2):148-65. PubMed ID: 8964033
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimicrobial susceptibility pattern in nosocomial infections caused by Acinetobacter species in Asir Region, Saudi Arabia.
    Abdalla NM; Osman AA; Haimour WO; Sarhan MA; Mohammed MN; Zyad EM; Al-Ghtani AM
    Pak J Biol Sci; 2013 Mar; 16(6):275-80. PubMed ID: 24498790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of bacteria of the Acinetobacter species].
    Seifert H
    Med Klin (Munich); 1992 Nov; 87(11):591-3. PubMed ID: 1470057
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidemiological characterization of hospital-acquired Acinetobacter baumannii isolates from a 1500-bed teaching hospital by phenotypic and genotypic methods.
    Basustaoglu AC; Kisa O; Sacilik SC; Ozyurt M; Yildiran ST
    J Hosp Infect; 2001 Mar; 47(3):246-7. PubMed ID: 11247688
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiology of Acinetobacter spp.-associated healthcare infections and colonization among children at a tertiary-care hospital in Saudi Arabia: a 6-year retrospective cohort study.
    Balkhy HH; Bawazeer MS; Kattan RF; Tamim HM; Al Johani SM; Aldughashem FA; Al Alem HA; Adlan A; Herwaldt LA
    Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2645-51. PubMed ID: 22476386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The increasing significance of outbreaks of Acinetobacter spp.: the need for control and new agents.
    Bergogne-Bérézin E
    J Hosp Infect; 1995 Jun; 30 Suppl():441-52. PubMed ID: 7560983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bacteria of the genus Acinetobacter: clinical significance and therapy of infections].
    Wróblewska M
    Pneumonol Alergol Pol; 2006; 74(2):227-31. PubMed ID: 17269375
    [No Abstract]   [Full Text] [Related]  

  • 8. [Strains of the genus Acinetobacter and their role in nosocomial infections].
    Fleischer M; Przondo-Mordarska A
    Postepy Hig Med Dosw; 1994; 48(2):127-41. PubMed ID: 7937396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical importance and antibiotic resistance of Acinetobacter spp. Proceedings of a symposium held on 4-5 November 1996 at Eilat, Israel.
    Towner KJ
    J Med Microbiol; 1997 Sep; 46(9):721-46. PubMed ID: 9303951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acinetobacter: microbiological, pathogenetic and resistant properties].
    Chebotar IV; Lazareva AV; Masalov YK; Mikhailovich VM; Mayanskiy NA
    Vestn Ross Akad Med Nauk; 2014; (9-10):39-50. PubMed ID: 25816642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acinetobacter baumannii resistant to everything: what should we do?
    Vila J; Pachón J
    Clin Microbiol Infect; 2011 Jul; 17(7):955-6. PubMed ID: 21722248
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter.
    Espinal P; Roca I; Vila J
    Future Microbiol; 2011 May; 6(5):495-511. PubMed ID: 21585259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emergence of multidrug resistant Acinetobacter species: a major concern in the hospital setting.
    Hanlon GW
    Lett Appl Microbiol; 2005; 41(5):375-8. PubMed ID: 16238638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the way of dealing with antibiotic exposure in studies assessing risk factors for drug-resistant pathogens.
    Prates CG; Zavascki AP
    Diagn Microbiol Infect Dis; 2009 May; 64(1):102; author reply 103. PubMed ID: 19232855
    [No Abstract]   [Full Text] [Related]  

  • 15. Acinetobacter baumannii--an emerging nosocomial pathogen in the burns unit Manipal, India.
    Sengupta S; Kumar P; Ciraj AM; Shivananda PG
    Burns; 2001 Mar; 27(2):140-4. PubMed ID: 11226651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global challenge of multidrug-resistant Acinetobacter baumannii.
    Perez F; Hujer AM; Hujer KM; Decker BK; Rather PN; Bonomo RA
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3471-84. PubMed ID: 17646423
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acinetobacter baumannii. An opportunistic pathogen offside?].
    Gobernado Serrano M
    Med Clin (Barc); 2012 Mar; 138(5):204-6. PubMed ID: 22075229
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful Eradication of Multidrug Resistant Acinetobacter in the Helsinki Burn Centre.
    Lindford A; Kiuru V; Anttila VJ; Vuola J
    J Burn Care Res; 2015; 36(6):595-601. PubMed ID: 25501783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial Resistance in
    Lupo A; Haenni M; Madec JY
    Microbiol Spectr; 2018 Jun; 6(3):. PubMed ID: 30101740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microbiological and therapeutic considerations of Acinetobacter spp. infection].
    López-Brea M; Alarcón T; López S
    Rev Esp Quimioter; 1998 Jun; 11(2):110-7. PubMed ID: 9795295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 42.